Skip to main content
. 2024 Jan 16;8(2):251–261. doi: 10.1007/s41669-023-00467-2

Table 3.

Multivariable regression impact of different variables on the duration of P&R negotiation (days)

P&R negotiation (days) Coefficient Standard error p value 95% CI
Added therapeutic value > 3a −79.6 36.3 0.023 −3.6 to −155.6
Managed entry agreement (yes) 140.8 68.9 0.048 5.8–275.8
Baseline 138.9 48.3 0.010 37.9–239.9

P&R price and reimbursement, CI confidence interval

aThe added therapeutic value is published only for indications subject to innovativeness appraisal, thus limiting the number of observations (n = 24)